Medical/Pharmaceuticals Newswire
Rite Aid Stores Stock Additional Emergency Supplies to Help Residents Prepare for Tropical Storm Hanna
CAMP HILL, Pa.-(Business Wire)-September 5, 2008 - As Tropical Storm Hanna heads toward the East Coast, Rite Aid stores in Georgia, South Carolina and North Carolina have stocked up on supplies to help residents get ready and urge them to plan ahead. All Rite Aid stores in those states have...
Dutton Associates Announces Investment Opinion: Neoprobe Rating Maintained at Strong Speculative Buy by Dutton Associates
ROSEVILLE, Calif.-(Business Wire)-September 5, 2008 - Dutton Associates continues coverage of Neoprobe Corporation (OTCBB: NEOP), maintaining its rating at Strong Speculative Buy and a higher price target of $1.50. The 15-page report by Dutton senior analyst Dennis C. Fisher, CFA is available at...
BioPharm America 2008 Presenter Profile for Debiopharm
ATLANTA-(Business Wire)-September 5, 2008 - BioPharm America 2008 takes place September 9 - 10, 2008 at the Grand Hyatt Atlanta in Buckhead. Listed below is Debiopharm's presenter profile. For in-depth information about BioPharm America 2008, visit...
Aeolus Pharmaceuticals Completes Second Closing of Senior Convertible Debt Financing
LAGUNA NIGUEL, Calif.-(Business Wire)-September 5, 2008 - Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) today announced that it has raised an additional $125,000 through the sale of $125,000 in aggregate principal amount of its newly issued Senior Convertible Notes and warrants to selected...
Techalt, Inc.'s Stan's Rodeo Ointment (SRO) has Successful Introduction at the 2008 Beijing Olympics
SEATTLE-(Business Wire)-September 5, 2008 - Techalt, Inc. (Pink Sheets:TCLT) ("Techalt" or "Company") announced that Stan's Rodeo Ointment ("SRO") was dispensed for use by athletes at the 2008 Beijing Olympic Games. SportPharm, SRO's compounder, and a U.S. Food and Drug Administration ("FDA...
Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
TARRYTOWN, N.Y.-(Business Wire)-September 5, 2008 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008. The presentation will provide an overview of the Company and its clinical and...
A New Potential Path to Curing Inflammatory Bowel Diseases Emerges through Gene Research Funded by the Crohn's & Colitis Foundation of America
NEW YORK-(Business Wire)-September 5, 2008 - In the September 5 issue of the journal Cell, a group of researchers led by Richard Blumberg, MD, Chief of the Division of Gastroenterology, Hepatology and Endoscopy at the Brigham and Women's Hospital and Professor of Medicine at Harvard Medical...
Ligand Pharmaceuticals and the SALK Institute Enter Settlement Agreement and Mutual Release of All Claims
SAN DIEGO-(Business Wire)-September 5, 2008 - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and The Salk Institute for Biological Studies (SALK) have entered into a Settlement Agreement and Mutual Release of All Claims (Settlement Agreement). Through the Settlement Agreement, the parties have...
Meridian Bioscience to Present at the Robert W. Baird 2008 Small Cap Healthcare Conference
CINCINNATI-(Business Wire)-September 5, 2008 - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that the Company has been invited to present at the Robert W. Baird 2008 Small Cap Healthcare Conference on Wednesday, September 10, 2008 at 12:50 p.m. ET at the Intercontinental...
NeurAxon's NXN-188 Demonstrates Pain Relief in Migraine with Aura
WALTHAM, Mass.-(Business Wire)-September 5, 2008 - NeurAxon, Inc., a developer of next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced data from its Phase 2 clinical trial of NXN-188 in patients with migraine. In the study, patients experiencing migraine...
Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer
CARLSBAD, Calif.-(Business Wire)-September 5, 2008 - Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the appointment of Joe Beery as head of Invitrogen's Global Information Technology, effective...
Celgene Corporation to Present at Morgan Stanley Global Healthcare Unplugged Conference
SUMMIT, N.J.-(Business Wire)-September 5, 2008 - Celgene Corporation (NASDAQ: CELG) today announced its presentation at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008 at 11:30 a.m. EDT will be webcast live and will be available in the investor relations...
ZIOPHARM Commences Randomized Phase II Study of Palifosfamide in Soft Tissue Sarcoma
NEW YORK-(Business Wire)-September 5, 2008 - ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), announced today that the first patient has been dosed in its international Phase II randomized controlled trial of palifosfamide (ZIO-201) in patients with soft-tissue sarcoma (STS): This is a Phase II multi-center...
Inhibiton Therapeutics' Researcher to Present at the Ehrlich II, 2ND World Conference on "Magic Bullets"
CENTENNIAL, Colo.-(Business Wire)-September 5, 2008 - Inhibiton Therapeutics, Inc. (OTCBB: IHBT) announced today that the principal researcher for its ICA-1 compound, Dr. Mildred Acevedo-Duncan, will present the work for ICA-1 entitled "PKC-i inhibition by ICA-1 reduces the cell proliferation of...
GlycoMimetics, Inc. Commences Phase 1 Clinical Trial of Lead Drug Candidate
GAITHERSBURG, Md.-(Business Wire)-September 5, 2008 - GlycoMimetics, Inc., a privately held company developing a new class of glycobiology-based therapies for a broad range of indications, today announced it has initiated a Phase 1 clinical trial for GMI-1070, its lead drug candidate for the...
Phase Forward Acquires Clarix LLC, Innovation Leader in Web-Integrated Interactive Response Technology (IRT) for Clinical Trials
WALTHAM, Mass.-(Business Wire)-September 5, 2008 - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has acquired privately held Clarix LLC, an innovative provider of fully Web-integrated interactive response...
An Essential and Comprehensive Report on Biopharmaceuticals in the US and European Markets
DUBLIN, Ireland-(Business Wire)-September 5, 2008 - Research and Markets concerning biopharmaceutical products! — Encyclopaedic monographs concentrate on products' biotechnology and commercial aspects — Includes all biopharmaceuticals - recombinant and other proteins, monoclonal...
Inverness Medical Launches Portable Blood Testing Monitor to Warn Patients and Their Physicians of Potential Blood Clots
SAN JOSE, Calif.-(Business Wire)-September 5, 2008 - Inverness Medical Physician Diagnostics Group, a division of Inverness Medical Innovations, today announced the launch of the INRatio(R)2 PT/INR Monitoring System, a portable device that measures blood-clotting time, also known as prothrombin...
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
CAMBRIDGE, Mass. & DUBLIN, Ireland-(Business Wire)-September 5, 2008 - Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) today announced the initiation of the first clinical trial of TYSABRI(R) (natalizumab) in oncology. The first dose of TYSABRI was administered yesterday in...
Guidance Software Shares Expertise at eDiscovery Event for Pharmaceutical, Biotech and Medical Device Industries
PASADENA, Calif.-(Business Wire)-September 4, 2008 - Guidance Software, Inc. (NASDAQ:GUID), the World Leader in Digital Investigations(TM), whose customers include many pharmaceutical and biotech companies, including Bristol-Meyers Squibb, Pfizer and Wyeth, today announced it will have a significant...
Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
CAMBRIDGE, Mass.-(Business Wire)-September 4, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the 3rd Annual Citi Biotech Day on Monday, September 8, 2008 at 1:50 p.m. EDT and at the Morgan Stanley Global Healthcare...
InSite Vision Announces Webcast of Presentation at The Wall Street Analyst Forum's 19th Annual Institutional Investor Conference
ALAMEDA, Calif.-(Business Wire)-September 4, 2008 - InSite Vision Incorporated (AMEX:ISV) today announced that S. Kumar Chandrasekaran, Ph.D., Chairman and Chief Executive Officer, will present an overview of the company at The Wall Street Analyst Forum's 19th Annual Institutional Investor...
Quinnova Pharmaceuticals, Inc. Announces Appointment of Senior Vice President of Research & Development
NEWTOWN, Pa.-(Business Wire)-September 4, 2008 - Quinnova Pharmaceuticals, Inc. announced today the appointment of Dr. Christopher Hensby as Senior Vice President Research & Development. Dr. Hensby will assume his new post starting in October of 2008. Dr. Hensby is a graduate BSc. in...
Total Learning Concepts Introduces Training Guide for Sales Representatives New to the Biopharma Industry
LAWRENCEVILLE, N.J.-(Business Wire)-September 4, 2008 - Total Learning Concepts, a training content company that specializes in e-Learning, has introduced a new, interactive training guide—Introduction to Pharmaceutical Sales—for sales representatives who are new to the pharmaceutical...
Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa.-(Business Wire)-September 4, 2008 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in...
PerkinElmer to Present at UBS Best of Americas Conference
WALTHAM, Mass.-(Business Wire)-September 4, 2008 - PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it will present at the UBS Best of Americas Conference on Thursday, September 11, 2008, at 13.50 p.m. British Summer Time at the UBS Conference...
Dutton Associates Announces Investment Opinion: NexMed Lowered To Speculative Buy Rating In Research Note By Dutton Associates
ROSEVILLE, Calif.-(Business Wire)-September 4, 2008 - Dutton Associates updates its coverage of NexMed (Nasdaq:NEXM), lowering its rating to Speculative Buy and a $1.00 price target. The research note by Dutton senior analyst Denise Resnik, MS is available at www.jmdutton.com as well as from First...
Abraxis and ProMetic Enter License Agreements for up to $295 M US for Four Biopharmaceuticals
LOS ANGELES & MONTREAL-(Business Wire)-September 4, 2008 - Abraxis BioScience, Inc. (NASDAQ:ABII) and ProMetic Life Sciences Inc. (TSX:PLI) announced today that they have signed definitive agreements for the development and commercialization, on a world-wide basis (excluding China and Taiwan...
Nine Rite Aid Stores Now Open in New Orleans Area to Accommodate Demand for Prescriptions as Thousands of Residents Flock to Local Hospitals to Get Them Filled
CAMP HILL, Pa.-(Business Wire)-September 4, 2008 - With thousands of residents returning to New Orleans and flocking to local hospitals to get prescriptions filled, Rite Aid said today it has reopened nine stores in the New Orleans area that can accommodate both Rite Aid and non-Rite Aid...
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
MUNICH-(Business Wire)-September 4, 2008 - Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER(R) Sirolimus-eluting Coronary Stent was comparable to bypass surgery (coronary artery bypass grafting or...
Kidz-Med Inc. to Supplement Product Line with All-Natural Children's Multivitamin
WESTON, Fla.-(Business Wire)-September 4, 2008 - Kidz-Med Inc. (the Company), a subsidiary of American Scientific Resources, Inc. (Pink Sheets:ASFX), today announced that they have introduced an all natural children's multivitamin to their health and safety product line on www.kidzmed.com. The...
Biogen Idec to Present at the 3rd Annual CITI Biotech Day
CAMBRIDGE, Mass.-(Business Wire)-September 4, 2008 - Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the CITI Biotech Day will be webcast live via the internet, on Monday, September 8, 2008 at 3:20 p.m. ET. To access the live webcast, please visit Biogen Idec's Investor...
Rite Aid Launches New Program to Make Refilling Prescriptions Easier; Patients Who Sign up for Courtesy Refill Program Have Chance to Win a 2008 Chevy Malibu Hybrid and $3,000 in Gas Gift Cards
CAMP HILL, Pa.-(Business Wire)-September 4, 2008 - To encourage patients to sign up for its new Automated Courtesy Refill program that makes it easier to refill their prescriptions, Rite Aid is giving those who enroll a chance to win a 2008 Chevy Malibu Hybrid car and $3,000 in gas gift cards...
Clinical Resource Network Named to 2008 Inc. 5000 List
DEERFIELD, Ill.-(Business Wire)-September 4, 2008 - Inc. announced it placed Clinical Resource Network (CRN) 2674th on its 2008 annual ranking of the 5,000 fastest-growing private companies in the country and in the Top 100 businesses in the greater Chicagoland area on August 20, 2008. The list is...
Minerva Settles Litigation
BOSTON-(Business Wire)-September 4, 2008 - Minerva Biotechnologies Corporation and James Czirr, its former Chief Executive Officer, today announced the resolution of their legal dispute. As part of the settlement, each of the parties withdrew all allegations of misconduct and the Company accepted...
The Great Atlantic & Pacific Tea Company's Live Better! Wellness Program Now Provides Full Pharmacy Benefits Management (PBM) Services
MONTVALE, N.J.-(Business Wire)-September 4, 2008 - The Great Atlantic & Pacific Tea Company, Inc. (A&P) (NYSE Symbol: GAP) today announced an innovative partnership with 4D Pharmacy Management Systems, Inc. which will enable the Company to administer employer group prescription drug benefits...
Philip A. Theodore Joins BioReliance Corporation as Vice President, Compliance, Legal and Corporate Development
ROCKVILLE, Md.-(Business Wire)-September 4, 2008 - BioReliance Corporation announced today that Philip A. Theodore has been named Vice President, Compliance, Legal and Corporate Development. BioReliance Corporation is a leading contract services company that provides biologics safety testing...
Aethlon Medical Releases Shareholder Letter
SAN DIEGO-(Business Wire)-September 4, 2008 - Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. To our Shareholders, September 2008 will be a pivotal month for our organization as we expect to initiate the...
Take Care Clinics Open at Two Walgreens in Louisville
LOUISVILLE, Ky.-(Business Wire)-September 4, 2008 - Take Care Health Systems, one of the largest managers of convenient care clinics and a wholly-owned subsidiary of Walgreens (NYSE, NASDAQ: WAG), has opened two Take Care Clinics at Walgreens drugstores in Louisville. The clinics are walk-in...
The Discovery Stage Partnering Agreements in Biopharma Report Provides Data on Deal Trends Since 2000, Over 1000 Actual Contracts and Real Case Studies
DUBLIN, Ireland-(Business Wire)-September 4, 2008 - Research and Markets Subject to being published via regulatory requirements of the Securities Exchange Commission. Report Scope: Discovery Stage Partnering Agreements in Biopharma is intended to provide the reader with an in-depth understanding of...
Dow Pharmaceutical Sciences, Inc. Expands Clinical Labeling Capabilities in Petaluma, California
PETALUMA, Calif.-(Business Wire)-September 4, 2008 - Dow Pharmaceutical Sciences, Inc. recently announced expansion of its internal clinical labeling printing capabilities. With the addition of non-smear thermal transfer printers and software that allows for uploading and printing of random codes...
Janet Wolfe, President of Wolfe Laboratories, Named Boston's Entrepreneur of the Year
WATERTOWN, Mass.-(Business Wire)-September 4, 2008 - Janet Wolfe, Ph.D., President of Wolfe Laboratories, Inc. (WLI), was named Boston's Entrepreneur of the Year by the Greater Boston Chamber of Commerce. The award recognizes the achievements of small business owners and their contributions to the...
Examine a Forecast Insight of the Antihypertensives Market as Key Patent Expiries Prevent Market Growth
DUBLIN, Ireland-(Business Wire)-September 4, 2008 - Research and Markets has announced the addition of the "Forecast Insight: Antihypertensives - Key Patent Expiries Prevent Market Growth" report to their offering. The antihypertensives market is expected to reach $37 billion, across the seven major...
A Pipeline Insight of the Cancer R&D Market: With a Focus on Lung, Brain, Head, Neck and Thyroid Tumors
DUBLIN, Ireland-(Business Wire)-September 4, 2008 - Research and Markets show great promise to compete with Erbitux in the head and neck cancer market, particularly due to potential toxicity advantages that fully human monoclonal antibodies may have. Key reasons to purchase this title - Identify...
ABMC Products to Be Used by the French Ministry of Interior
KINDERHOOK, N.Y.-(Business Wire)-September 4, 2008 - American Bio Medica Corporation (NASDAQ:ABMC) announced today that they have been awarded, through their master European distributor, MAVAND Solutions GmbH, a government tender with the French Ministry of Interior. Effective immediately, the...
LifeVantage Corporation Invited to Present at EdgeWater Research Small/Micro Cap Conference September 24th and 25th, 2008
SAN DIEGO-(Business Wire)-September 4, 2008 - LifeVantage Corporation (OTCBB: LFVN), the maker of Protandim(R), the only product clinically proven to slow the progressive rate of aging, today announced that the senior management team has been invited to present at the upcoming EdgeWater Research...
BIOMAX INFORMATICS AG Releases the New BioXM Version 3.0, A Major Upgrade of Its Flagship Enterprise Platform for Semantic Data Integration and Knowledge Management
MARTINSRIED, Germany-(Business Wire)-September 4, 2008 - Biomax Informatics today announced the new release of a major upgrade of its flagship product BioXM(TM) Knowledge Management Environment. The BioXM system integrates information from different data sources to dynamically build semantic...
'HealthGate Governance(TM)' Application Addresses Mounting Requirements for Governance, Transparency and Accountability in Healthcare Quality and Improvement Initiatives
BURLINGTON, Mass.-(Business Wire)-September 4, 2008 - HealthGate Data Corp. announced today the availability of HealthGate Governance(TM), a collection of web-based tools designed specifically to help hospitals and health systems manage the complex governance issues associated with quality and...
Q Pharma, Inc. Names Bryan Koslow Vice President of Sales and Marketing
MORRISTOWN, N.J.-(Business Wire)-September 4, 2008 - Q Pharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today that Bryan Koslow has joined the firm as Vice President of Sales and Marketing. In this role, Koslow will lead the development and execution of Q...
NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex(R) Tablets
FLEMINGTON, N.J.-(Business Wire)-September 4, 2008 - NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced data from its Pilot Efficacy Study of its Oral Spray formulation of sumatriptan...
Synageva BioPharma Appoints Sanj K. Patel President and Chief Executive Officer and Opens New Corporate Headquarters
WALTHAM, Mass.-(Business Wire)-September 4, 2008 - Synageva BioPharma announced today the appointment of Sanj K. Patel as President and Chief Executive Officer. Sanj joins Synageva from Genzyme Therapeutics and brings experience from one of the industry's leading biopharmaceutical producers and an...
Nanotherapeutics Files Investigational New Drug Application for NanoDOX(TM) Hydrogel to Treat Lower Extremity Diabetic Ulcers
ALACHUA, Fla.-(Business Wire)-September 4, 2008 - Nanotherapeutics, a privately held specialty biopharmaceutical company, announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX(TM) Hydrogel, a...
Gryphon Investors Recapitalizes Synteract and Vince & Associates
SAN FRANCISCO-(Business Wire)-September 4, 2008 - Gryphon Investors announced today that it led the simultaneous recapitalization of Synteract, Inc. ("Synteract") and Vince & Associates Clinical Research ("VNA") in partnership with management and Celerity Partners. Both Synteract and VNA provide...
Amrubicin Receives FDA Fast Track Designation for the Treatment of Small Cell Lung Cancer after First-Line Chemotherapy
SUMMIT, N.J.-(Business Wire)-September 4, 2008 - Celgene Corporation (NASDAQ: CELG) today announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy. A drug...
NeoPharm Granted Additional Time to Regain Listing Compliance on NASDAQ
LAKE BLUFF, Ill.-(Business Wire)-September 4, 2008 - NeoPharm, Inc. (NASDAQ: NEOL), today announced that, on September 2, 2008, the Company received a letter from the NASDAQ Listing Qualifications Panel (the "Panel") informing the Company that the Panel had determined to grant the Company's...
Rite Aid August Same Store Sales Increase 1.1 Percent
CAMP HILL, Pa.-(Business Wire)-September 4, 2008 - Rite Aid Corporation (NYSE:RAD) today announced sales results for August. Monthly Sales For the five weeks ended August 30, 2008, same store sales increased 1.1 percent over the prior-year period. Front-end same store sales were up 3.7 percent...
Cougar Biotechnology to Present at Morgan Stanley Global Healthcare Conference
LOS ANGELES-(Business Wire)-September 4, 2008 - Cougar Biotechnology, Inc. (NASDAQ: CGRB) today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, at 9:10 a.m. EDT at the...
MDRNA Receives Additional Funding from National Institutes of Health
BOTHELL, Wash.-(Business Wire)-September 4, 2008 - MDRNA, Inc. (Nasdaq: MRNA) announced today that the National Institutes of Health (NIH) has awarded the Company over $350,000 for further development of the Company's siRNA therapeutics program to prevent and treat influenza. These funds are part of...
FDA Assigns Priority Review to GTC Biotherapeutics' ATryn(R)
FRAMINGHAM, Mass.-(Business Wire)-September 4, 2008 - The US Food and Drug Administration, or FDA, has assigned Priority Review to GTC Biotherapeutics, Inc.'s ("GTC", Nasdaq: GTCB) Biologic License Application, or BLA, for ATryn(R). Priority Review is granted to applications for products that, if...
Isis Receives Notices of Allowance That Significantly Expand the Scope of Key RNA Therapeutic Patents
CAMBRIDGE, Mass. & CARLSBAD, Calif.-(Business Wire)-September 4, 2008 - Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and the companies' joint venture Regulus Therapeutics LLC, announced today that the United States Patent and Trademark Office (USPTO...
Invitrogen Launches Patent Licensing Program for Enabling Amplification Technology
CARLSBAD, Calif.-(Business Wire)-September 4, 2008 - Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced that it has signed non-exclusive agreements with New England Biolabs, Inc., QIAGEN GmbH, and...
Geron Corporation to Present at Thomas Weisel Partners Healthcare Conference
MENLO PARK, Calif.-(Business Wire)-September 4, 2008 - Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company's product development programs at 9:45 am EDT on Friday, September 5, 2008, at the...
Announcing a Monumental Gathering for Laser Innovation
-(Business Wire)-September 4, 2008 - Mark your calendars for the premier educational gathering of the world's leading laser experts hosted by the American Society for Laser Medicine and Surgery. WHO: The American Society for Laser Medicine and Surgery (ASLMS), the world's preeminent resource for...
Pediatrix Completes New $350 Million Credit Facility
FORT LAUDERDALE, Fla.-(Business Wire)-September 4, 2008 - Pediatrix Medical Group, Inc. (NYSE:PDX) today announced that it has completed a new $350 million revolving credit facility that will provide a funding source for acquisitions, as well as other corporate purposes. The credit facility also...
EPIX Pharmaceuticals To Regain Full Worldwide Commercial Rights For Vasovist(R)
LEXINGTON, Mass.-(Business Wire)-September 4, 2008 - EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that Bayer...
Anadis Commercializing "BioGard" Adjunctive Therapy for HIV & AIDS
MELBOURNE, Australia-(Business Wire)-September 4, 2008 - Anadis (ASX: ANX; OTC: ANDIY) announced today its commercialization of a new product, BioGard(TM), intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons...
Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration
BOTHELL, Wash. & TOKYO-(Business Wire)-September 4, 2008 - Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. announced today that they have entered into a definitive agreement to co-develop Acucela's lead compound ACU-4429 which is currently in Phase I clinical development for the dry form of...
Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for Rebamipide Ophthalmic Suspension for Dry Eye
BOTHELL, Wash. & TOKYO-(Business Wire)-September 4, 2008 - Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. today announced that they have entered into a definitive agreement to co-develop Rebamipide ophthalmic suspension (hereinafter, Rebamipide), Otsuka's proprietary compound for the treatment...
Indian Pharma Industry Monitor Delivers Complete Summary and Analysis of the Indian Pharma Market
DUBLIN, Ireland-(Business Wire)-September 4, 2008 - Research and Markets has announced the addition of the "Indian Pharma Industry Monitor" report to their offering. The Indian Pharma Industry Monitor gives a summary and analysis of the Indian pharma market including, mergers, acquisitions...
CORRECTING and REPLACING Cosmederm Technologies Announces Partnership with Dr. Reddy's for Indian Distribution of Proprietary Skin Care Products
HYDERABAD, India & LA JOLLA, Calif.-(Business Wire)-September 4, 2008 - Please replace with the following corrected version due to incorrect contact information. The corrected release reads: COSMEDERM TECHNOLOGIES ANNOUNCES PARTNERSHIP WITH DR. REDDY'S FOR INDIAN DISTRIBUTION OF PROPRIETARY SKIN...
AVANIR to Present at The Wall Street Analyst Forum Conference
ALISO VIEJO, Calif.-(Business Wire)-September 4, 2008 - AVANIR Pharmaceuticals (NASDAQ: AVNR) today announced that Keith Katkin, President and Chief Executive Officer, will present at The Wall Street Analyst Forum 19th Annual Analyst Conference on Wednesday, September 10 at 11:10 a.m. Eastern time...
Natrix Separations Announces $19 Million Series B Financing
BURLINGTON, Ontario-(Business Wire)-September 3, 2008 - Natrix Separations Inc., a privately held company that develops and manufactures high performance, membrane-based disposable chromatography products, announced today that it has closed a Series B financing totaling $19 Million. The round was...
Academic Leaders Join Advisory Board of Assay Depot, the World's First Drug Discovery Outsourcing Marketplace
SAN DIEGO-(Business Wire)-September 3, 2008 - Assay Depot announced today that leading researchers from Harvard, Stanford, the University of California, San Francisco (UCSF) and the University of Texas had joined its Advisory Board. Assay Depot is the world's first full-service outsourcing...
Precision Dynamics Releases New Ident-Alert(TM) Colored Snaps Providing Hospitals with Quick and Easy Patient Alert ID
SAN FERNANDO, Calif.-(Business Wire)-September 3, 2008 - Precision Dynamics Corporation (PDC), the leader of automated wristband identification, announces the release of Ident-Alert(TM) Colored Snaps. As the newest addition to PDC's Alert Band(R) ID products, Ident-Alert(TM) Colored Snaps will...
Ferro Announces Appointment of Mark Duesenberg as Vice President, General Counsel and Secretary
CLEVELAND-(Business Wire)-September 3, 2008 - Ferro Corporation (NYSE: FOE) has announced that Mark H. Duesenberg will join the Company on September 17, 2008, as Vice President, General Counsel and Secretary. Mr. Duesenberg, 46, brings extensive legal experience at multinational companies to...
Celgene Corporation to Present at the 3rd Annual Citi Biotech Day
SUMMIT, N.J.-(Business Wire)-September 3, 2008 - Celgene Corporation (NASDAQ: CELG) today announced its presentation at the 3rd Annual Citi Biotech Day on Monday, September 8, 2008 at 9:00 a.m. EDT will be webcast live and will be available in the investor relations section of the company's Web site...
AMRI Announces Leadership Changes in Pharmaceutical Development and Manufacturing
ALBANY, N.Y.-(Business Wire)-September 3, 2008 - AMRI (NASDAQ: AMRI) announced today that Steven R. Hagen, Ph.D. has been promoted to vice president of pharmaceutical development and manufacturing, reporting to AMRI Chairman, President and CEO Thomas E. D'Ambra, Ph.D. Previously, Dr. Hagen was...
Biodel to Report Results of VIAject(TM) Pivotal Phase III Clinical Trials at EASD Conference
DANBURY, Conn.-(Business Wire)-September 3, 2008 - Biodel Inc. (Nasdaq: BIOD) announced today that it will report results of its two pivotal Phase III clinical trials of VIAject(TM) in patients with Type 1 and Type 2 diabetes next week at the 44th Annual Meeting of the European Association for the...
Biovail Announces Filing of ANDA for Fenofibrate Tablets
TORONTO-(Business Wire)-September 3, 2008 - Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the United States Food and Drug Administration (FDA) has accepted the Company's abbreviated new drug application (ANDA) for a generic formulation of 145mg and 48mg strengths of fenofibrate...
Free Rite Aid RX Savings Card Now Available in California So Residents Can Save on More Than 10,000 Prescription Drugs; Success of Card in Michigan, North Carolina, South Carolina and Georgia Prompts Nationwide Debut Later This Month
CAMP HILL, Pa.-(Business Wire)-September 3, 2008 - California residents can realize significant savings on more than 10,000 prescription drugs with the free Rite Aid RX Savings Card just made available at Rite Aid drugstores across the state and soon to be offered at all Rite Aid stores across the...
Walgreens Offers Medication Advice Ahead of Potential Hurricane Hanna
DEERFIELD, Ill.-(Business Wire)-September 3, 2008 - As Tropical Storm Hanna moves toward the Florida coast and threatens to develop into a hurricane, Walgreens is offering residents tips on refilling their prescription medications should they need to evacuate. To help pharmacy patients prepare for...
Emergent BioSolutions Receives $24 Million Development Contract from the Department of Health and Human Services to Fund Continued Development of Anthrax Monoclonal Antibody
ROCKVILLE, Md.-(Business Wire)-September 3, 2008 - Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has received a contract from the Department of Health and Human Services (HHS) for over $24.3 million to fund the further development of Emergent's anthrax monoclonal antibody AVP-21D9...
Teva and Barr Receive FTC Request for Additional Information
JERUSALEM & MONTVALE, N.J.-(Business Wire)-September 3, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that, as expected, each party has received a request for additional information (commonly referred to as a "second...
Aerodyne Announces The Vacu-Valve(R) Platypus Dust Valve as an Original, Low-Cost Solution in Powder Handling
CLEVELAND-(Business Wire)-September 3, 2008 - Aerodyne(R), a division of Abanaki Corporation, announces the new Vacu-Valve(R) Platypus, one of the lowest-cost, lowest-maintenance dust collector valves available. The Vacu-Valve Platypus operates as a constant discharge valve for dust collectors...
Genelabs Technologies, Inc. Announces Appointment of Frederick W. Driscoll as President and CEO
REDWOOD CITY, Calif.-(Business Wire)-September 3, 2008 - Genelabs Technologies, Inc. (NASDAQ:GNLB) today announced the appointment of Frederick W. Driscoll as President and Chief Executive Officer and as a member of its Board of Directors. Genelabs is a biopharmaceutical company focused on the...
Commonwealth Biotechnologies, Inc. Reports Progress on its new Laboratories in China
RICHMOND, Va.-(Business Wire)-September 3, 2008 - Commonwealth Biotechnologies, Inc. ("CBI") (NASDAQ Capital Market: CBTE) is pleased to provide an update regarding Venturepharm (Asia), CBI's joint venture with Venturepharm Laboratories Ltd ("VPL") (HKEX: 8225.HK). The joint venture was...
PraxisDirect 2.0 Forecasts Enrollment Success
NASHVILLE, Tenn.-(Business Wire)-September 3, 2008 - Praxis, a company specializing in centralized patient recruitment for clinical research studies, is proud to announce the release of PraxisDirect 2.0, the most advanced technology in patient recruitment management. Hundreds of thousands of...
Walgreens Prescription Savings Club Tops One Million Members
DEERFIELD, Ill.-(Business Wire)-September 3, 2008 - More than one million pharmacy patients are now enrolled in Walgreens (NYSE:WAG)(NASDAQ:WAG) Prescription Savings Club, the retail pharmacy industry's most comprehensive prescription discount plan. Each day, thousands of new members opt to take...
Genetix Group plc Awarded Scottish NHS Cytogenetics Contract
NEW MILTON, UK-(Business Wire)-September 3, 2008 - Genetix Group plc (AIM: GTX), the cancer diagnostic and biopharmaceutical technologies group, today announces that it has been awarded a contract to develop and implement a nationwide network of Automated Cytogenetic Analysis Systems by NHS National...
SK&A Board of Directors Promotes David Escalante, Jr. to President and CEO
IRVINE, Calif.-(Business Wire)-September 3, 2008 - Stuart Krasney, founder and Chairman of the Board of SK&A, a leading provider of healthcare information solutions and research, today announced the promotion of David Escalante, Jr. to the position of Chief Executive Officer. The promotion makes...
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
PARSIPPANY, N.J.-(Business Wire)-September 3, 2008 - The Medicines Company (NASDAQ:MDCO) today announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in...
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
NEW YORK-(Business Wire)-September 3, 2008 - ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) to broaden the use of ERBITUX(R) (cetuximab) to include first-line treatment of patients with recurrent...
Alte Biosciences Files Patent for New Inflammatory Bowel Disease Drugs
CARY, N.C.-(Business Wire)-September 3, 2008 - Alte Bioscience, Inc., a development stage pharmaceutical company, is pleased to announce the filing of a provisional patent for a new class of drugs that may benefit patients with inflammatory bowel disease. This is the latest in a series of...
Research and Markets: Examine BSD Medical Corporation's Product Pipeline with New Analysis
DUBLIN, Ireland-(Business Wire)-September 3, 2008 - Research and Markets has announced the addition of the "BSD Medical Corporation Product Pipeline Analysis" company profile to their offering. This report is an insightful source for data, analysis and strategic insights into a BSD Medical...
Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 8, 2008
AMITYVILLE, N.Y.-(Business Wire)-September 3, 2008 - Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its first quarter of Fiscal Year 2009 ended July 31, 2008, prior to the market opening on Monday September 8, 2008 and will hold a conference call to...
Wall Street Analyst Forum 2008 Presenter Profiles for AVANIR Pharmaceuticals and DRI Corporation
NEW YORK-(Business Wire)-September 3, 2008 - Wall Street Analyst Forum 2008 takes place September 08, 2008 - September 10, 2008 at The University Club in New York City. Listed below are the Wall Street Analyst Forum 2008 presenter profiles for Avanir Pharmaceuticals and DRI Corporation. For in-depth...
Heartbeat Digital Recognized as Google Adwords-Qualified Agency
NEW YORK-(Business Wire)-September 3, 2008 - Heartbeat Digital, an Interactive media agency based in Manhattan, has been named an official Google AdWords Qualified Company. To merit this recognition, Heartbeat was rigorously tested using Google's highly competitive Advertising Professionals exam...
The Latest Competitor Analysis Report on Emerging Diabetes Drugs Reveals an Increasing Focus on Preserving or Regenerating Pancreatic Islet Cell Mass
DUBLIN, Ireland-(Business Wire)-September 3, 2008 - Research and Markets - Roche - Sanofi-Aventis - Takeda Pharmaceutical - Transition Therapeutics - TransTech Pharma For more information visit http://www.researchandmarkets.com/research/d99eac/competitor_analysi
Research and Markets: A Competitor Analysis Report of Toll-Like Receptor (TLR) Agonists & Antagonists
DUBLIN, Ireland-(Business Wire)-September 3, 2008 - Research and Markets for TLR Agonists, Antagonists, Adjuvants and TLR-Adjuvanted Vaccines is contained in this Competitor Analysis. -0- *T The report includes a compilation of current active projects in the research and development of TLR...
XenoPort to Present at the Morgan Stanley Healthcare Conference
SANTA CLARA, Calif.-(Business Wire)-September 3, 2008 - XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Unplugged Conference. The live presentation will occur at 8:30 a.m. Pacific Time...
Rexahn Pharmaceuticals Expands Cancer Patent Portfolio
ROCKVILLE, Md.-(Business Wire)-September 3, 2008 - Rexahn Pharmaceuticals, Inc. (AMEX: RNN), a leader in innovative therapeutics for life-threatening and life-debilitating diseases, announced today that the U.S. Patent & Trademark Office has issued a new cancer patent (U.S. Patent 7,405,214...
Azaya Therapeutics Licenses Promising Treatment for Head and Neck Cancers
SAN ANTONIO-(Business Wire)-September 3, 2008 - Azaya Therapeutics, Inc., announced today that it has signed a licensing agreement to further develop a breakthrough technology that uses liposomes to deliver radiation through direct injection into head and neck tumors, shrinking the tumor, delaying...
Concept Media Nominated for Prestigious FREDDIE Award for Excellence in Healthcare Media
IRVINE, Calif.-(Business Wire)-September 3, 2008 - Concept Media, a leading producer and distributor of healthcare education media, has been announced as a 2008 FREDDIE Award finalist for its series, "Domestic Violence: Portrait of Abuse". The FREDDIE Awards are also known as, "the Oscars for...
eFoodSafety Commences Marketing Campaign for Cinnechol(TM) with National Radio Blitz
SCOTTSDALE, Ariz.-(Business Wire)-September 3, 2008 - eFoodSafety.com, Inc. (OTCBB:EFSF), a researcher, developer, and marketer of whole foods and nutraceutical products, announced today that its half-hour radio show campaign for its all-natural product Cinnechol(TM) had commenced the weekend of...
ViroPharma and Lev Receive Hart-Scott-Rodino Clearance from the Federal Trade Commission
EXTON, Pa.-(Business Wire)-September 3, 2008 - ViroPharma Incorporated (Nasdaq: VPHM) and Lev Pharmaceuticals, Inc. (OTCBB: LEVP) today announced that the waiting period required under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act has expired in connection with ViroPharma's proposed...
Bristol-Myers Squibb and AstraZeneca to Hold Investor Teleconference to Discuss EASD Highlights
NEW YORK-(Business Wire)-September 3, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) will host a conference call at 9 a.m. (ET) on Tuesday, September 9 to review data presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD), being...
Gamma Pharmaceuticals Inc. Receives Certificate of Hygiene for Products in China
LAS VEGAS-(Business Wire)-September 3, 2008 - Gamma Pharmaceuticals Inc. (OTCBB: GMPM) announced today that the Company's China-based operation has received its Certificate Of Hygiene from the Customs Office in the People's Republic of China. The Certificate of Hygiene is a requirement for any...
BioImagene Appoints Prominent Pathologist Dr. Robert J. Monroe as Chief Medical Officer
CUPERTINO, Calif.-(Business Wire)-September 3, 2008 - BioImagene, the leader in providing innovative and affordable digital pathology solutions for cancer diagnosis and research, strengthened its executive team with the appointment of Robert J. Monroe, M.D., Ph.D., as Chief Medical Officer (CMO...
Helix BioMedix Announces License Agreement with Rodan & Fields, LLC
BOTHELL, Wash.-(Business Wire)-September 3, 2008 - Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced that it has licensed its new patent pending PiP3(TM) technology to Rodan + Fields(R) Dermatologists, a leading clinical skincare brand by Stanford...
Plexxikon Initiates Phase 1 Trial for PLX5568
BERKELEY, Calif.-(Business Wire)-September 3, 2008 - Plexxikon Inc. today announced that it has initiated a Phase 1 human clinical trial for PLX5568, a novel kinase inhibitor targeted for the treatment of at least two major indications with unmet medical needs: pain as well as polycystic kidney...
Millipore Forms Collaboration with Agilent Technologies to Expand Capabilities in Epigenetics Research Market
BILLERICA, Mass. & SANTA CLARA, Calif.-(Business Wire)-September 3, 2008 - Millipore Corporation (NYSE: MIL) and Agilent Technologies Inc. (NYSE: A) today announced they have formed a collaboration to develop innovative ChIP (chromatin immunoprecipitation) kits for the fast-growing epigenetics...
Acsis Executives to Speak at RFID World 2008
MARLTON, N.J.-(Business Wire)-September 3, 2008 - Acsis, Inc. , a leader in track and trace solutions for supply chain safety, security and efficiency, today announced that CEO Stewart McCutcheon and Executive Vice President Andre Pino, will each be speaking at RFID World 2008, September 8-10...
Aeris Therapeutics Announces Phase 2 Trial Results for Non-Surgical Emphysema Treatment
WOBURN, Mass.-(Business Wire)-September 3, 2008 - Aeris Therapeutics, Inc. (www.aerist.com), a company specializing in the development and commercialization of novel treatments for patients with emphysema and other advanced lung diseases, today announced that the primary efficacy endpoint in Phase 2...
DiaKine Therapeutics Announces Financing and New Board Member
CHARLOTTESVILLE, Va.-(Business Wire)-September 3, 2008 - DiaKine Therapeutics, developers of drugs designed to cause diabetes to go into remission, today announced that BlueTree Allied Angels has invested in the company. Additionally, J. James Frost M.D., Ph.D., M.B.A, has been elected as BlueTree's...
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
FORT LEE, N.J.-(Business Wire)-September 3, 2008 - Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, and Aegera Therapeutics, a private clinical stage company focused on oncology and neuropathic...
Brian Hare Joins PBE as Senior VP--New Business Acquisition
PRINCETON, N.J.-(Business Wire)-September 3, 2008 - Princeton Brand Econometrics (PBE) announced today that Brian M. Hare, former Senior Product Manager for Solvay Pharmaceuticals Inc, has joined the Company as Senior Vice President-Director New Business Acquisition & Development. "Brian has a...
Affymetrix Launches 3' IVT Express Kit for Faster, More Reliable Target Preparation
SANTA CLARA, Calif.-(Business Wire)-September 3, 2008 - Affymetrix Inc. (Nasdaq:AFFX) today announced the launch of its 3' IVT Express Kit, a faster and more reliable option for manual target preparation on Affymetrix' industry-standard 3' IVT array cartridges. The kit offers new streamlined...
CardioNet Announces Humana Upgrades CardioNet System to Covered Benefit Status
CONSHOHOCKEN, Pa.-(Business Wire)-September 3, 2008 - CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced that Humana, a large healthcare third-party payor, upgraded the CardioNet...
Walgreens August Sales Increase 6.0 Percent
DEERFIELD, Ill.-(Business Wire)-September 3, 2008 - Walgreens (NYSE:WAG)(NASDAQ:WAG) had August sales of $4,903,100,000, an increase of 6.0 percent from $4,625,540,000 for the same month in 2007. Sales in comparable stores (those open at least a year) rose 0.9 percent, while comparable store...
57 Start-Up Device Companies Confirmed to Present at Medtech Insight/Windhover Information's "Investment In Innovation (In3) East" Conference
IRVINE, Calif.-(Business Wire)-September 3, 2008 - Medtech Insight, a division of FDC-Windhover, an Elsevier company, and a leading provider of business information for the medical device industry, has announced that 57 early- to late-stage companies are now confirmed to present at their upcoming...
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
CAMBRIDGE, Mass. $ CARLSBAD, Calif.-(Business Wire)-September 3, 2008 - Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced...
Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems
EAST HILLS, N.Y.-(Business Wire)-September 3, 2008 - Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, announced today the purchase of GeneSystems, a privately held French biotechnology company that has developed a unique, easy-to-use and cost-effective...
OSI Pharmaceuticals Initiates Clinical Development Program for Anti-Diabetes Candidate, PSN821
MELVILLE, N.Y.-(Business Wire)-September 3, 2008 - OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that it has initiated a first-in-human clinical study for its G-protein coupled receptor GPR119 agonist, PSN821, which the Company is developing for the treatment of type 2 diabetes...
Celgene Corporation to Present at the Thomas Weisel Partners Experts in Growth Healthcare Conference 2008
SUMMIT, N.J.-(Business Wire)-September 3, 2008 - Celgene Corporation (NASDAQ: CELG) today announced its presentation at the Thomas Weisel Partners Experts in Growth Healthcare Conference 2008 on Friday, September 5, 2008 at 9:10 a.m. EDT will be webcast live and will be available in the investor...
Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program
THE WOODLANDS, Texas-(Business Wire)-September 3, 2008 - Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced the establishment of a...
Applied Biosystems to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference on September 9
FOSTER CITY, Calif.-(Business Wire)-September 3, 2008 - Applied Biosystems Inc. (NYSE:ABI) announced today that it will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9. Dennis Winger, Chief Financial Officer, will provide a brief opening statement...
LUNESTA(R) Next-Day Function and Discontinuation Data from a Long-Term 12-Week Study in Elderly Patients Presented at ECNP
MARLBOROUGH, Mass.-(Business Wire)-September 3, 2008 - Sepracor Inc. (Nasdaq: SEPR) today announced the presentation of LUNESTA(R) brand eszopiclone Phase IV study data at the 21st European College of Neuropsychopharmacology (ECNP) Congress in Barcelona. The poster presentations reflected results...
Phase III U.S. Pivotal Study Results on CSL Biotherapies' Afluria(R) Published in Vaccine
KING OF PRUSSIA, Pa.-(Business Wire)-September 3, 2008 - Phase III pivotal study findings in the journal Vaccine showed that two formulations of CSL Biotherapies' influenza virus vaccine Afluria(R) elicited an immune response (also known as immunogenicity) in healthy adults aged 18 - less than 65...
Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market Dimebon for the Treatment of Alzheimer's and Huntington's Diseases
NEW YORK & SAN FRANCISCO-(Business Wire)-September 3, 2008 - Pfizer Inc (NYSE: PFE) and Medivation, Inc.(NASDAQ: MDVN) announced today that they have entered into an agreement to develop and commercialize Dimebon, Medivation's investigational drug for treatment of Alzheimer's disease and...
Hadasit's Double Lumen PCI Guiding Catheter Prototype Demonstrates to be the First Guiding Catheter to Successfully Enable Administration of Medicine Directly to the Coronary Artery Throughout the Course of a PCI
EIN KEREM, Israel-(Business Wire)-September 3, 2008 - Hadasit, the technology transfer company of Hadassah Medical Organization, announced today the successful pre-clinical testing of a prototype of the Double Lumen PCI Guiding Catheter for use in the treatment of coronary artery disease. Unlike...
Antares Pharma Enters Into a Feasibility Development Agreement with Dr. Reddy's Laboratories, Inc. for an Enhanced Dermatology Product Utilizing the ATD Gel Platform
EWING, N.J.-(Business Wire)-September 3, 2008 - Antares Pharma, Inc. (AMEX:AIS) a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, today announced that they have entered into a development agreement with Dr. Reddy's Laboratories, Inc...
China Pharmaceutical Logistics Industry Report, 2008
DUBLIN, Ireland-(Business Wire)-September 3, 2008 - Research and Markets Medicine Logistics Center -Nantong Suzhong Pharmaceutical Logistics Center -Chongqing Modern Medicine Logistics Center Project -Projected Invested by Inflow of Foreign Capital *T For more information visit...
ZymoGenetics and Merck Serono Restructure Partnership
SEATTLE-(Business Wire)-September 3, 2008 - ZymoGenetics, Inc. (NASDAQ: ZGEN) today announced a restructuring of its partnership with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. With respect to the ongoing development of atacicept, ZymoGenetics exercised its contractual right to...
Clarient to Present at the Baird Small Cap Health Care Conference on September 10
ALISO VIEJO, Calif.-(Business Wire)-September 3, 2008 - Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced that its Vice Chairman and CEO Ron Andrews is scheduled to...
Regeneron's ARCALYST(R) (rilonacept) Reduced Incidence of Gout Flares by 81 Percent in a Phase 2 Study in Gout Patients Initiating Urate-Lowering Therapy
TARRYTOWN, N.Y.-(Business Wire)-September 3, 2008 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that treatment with ARCALYST(R) (rilonacept), also known as IL-1 Trap, in a Phase 2 study of gout patients initiating therapy with allopurinol to lower their uric acid levels...
Quotient Bioscience Receives Strategic Investment of GBP 35 Million from TA Associates
NEWMARKET, United Kingdom-(Business Wire)-September 3, 2008 - Quotient Bioscience Group Limited ("Quotient" or "the Company"), a leading provider of analytical and safety evaluation services and products for bioscience and sport, today announced it has raised a significant minority investment of...
Clinical Trial Protocol Against Cancer Therapy Side Effects (Mucositis) Approved
MELBOURNE, Australia-(Business Wire)-September 3, 2008 - Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and other proteins is announcing the clinical protocol for its Cancer-related Mucositis Program...
CORRECTING and REPLACING Rite Aid Starts Reopening Gulf Coast Stores After Hurricane Gustav
CAMP HILL, Pa.-(Business Wire)-September 3, 2008 - Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: RITE AID STARTS REOPENING GULF COAST STORES AFTER HURRICANE GUSTAV Hurricane Gustav Evacuees Can Fill Prescriptions at Any Open...
This Report Reveals the Findings of the Pharmaceutical Raw Materials Manufacturing in China
DUBLIN, Ireland-(Business Wire)-September 3, 2008 - Research and Markets - Current Prices Table - Real Growth Table - Ratio Table - Statistics Available Include: Revenue, Industry Gross Product, Enterprises, Establishments, Employment, Imports, Exports, Assets, Total Wages, Domestic Demand...
Regeneron Announces Webcast Presentation of Results from Phase 2 Study of ARCALYST(R) (rilonacept) in Gout Patients Initiating Urate-Lowering Therapy
TARRYTOWN, N.Y.-(Business Wire)-September 2, 2008 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that Dr. Leonard S. Schleifer, President and Chief Executive Officer of Regeneron, and other members of senior management will host a webcast conference call commencing at 8:30 a.m...
ATEL Ventures Portfolio Company, Adenosine Therapeutics to be Acquired by Clinical Data, Inc.
SAN FRANCISCO-(Business Wire)-September 2, 2008 - ATEL Ventures, a leading provider of secured financing to emerging growth companies, is pleased to announce that Clinical Data, Inc. has entered into an agreement to acquire Adenosine Therapeutics, an ATEL portfolio company. Clinical Data...
Cell Genesys to Present at the NewsMakers in the Biotech Industry Conference
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 2, 2008 - Cell Genesys, Inc. (Nasdaq:CEGE) today announced that Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will present a company update at the NewsMakers in the Biotech Industry Conference in New York...
Celgene Corporation to Present at the NewsMakers in the Biotech Industry Conference
SUMMIT, N.J.-(Business Wire)-September 2, 2008 - Celgene Corporation (NASDAQ: CELG) today announced its presentation at the NewsMakers in the Biotech Industry Conference on Thursday, September 4, 2008 at 2:00 p.m. EDT will be webcast live and will be available in the investor relations section of...
Sucampo Pharmaceuticals Limited Appoints New Head of Business Development
BETHESDA, MD-(Business Wire)-September 2, 2008 - Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced the appointment of Masanori Ueda as Senior Vice President, Business Development at Sucampo Pharma, Ltd., Chiyoda-ku, Tokyo, Japan, a wholly-owned subsidiary, effective September 1, 2008...
Cougar Biotechnology to Present at Citi Biotech Day
LOS ANGELES-(Business Wire)-September 2, 2008 - Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at the 3rd Annual Citi Biotech Day on Monday, September 8, at 11:15 a.m. EDT at the Citi Executive...
Somaxon Presents Pharmacological Data on Doxepin at the 21st European College of Neuropsychopharmacology Congress
SAN DIEGO-(Business Wire)-September 2, 2008 - Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology, today...
Alkermes' Corporate Presentation to be Webcast at Two Upcoming Investor Conferences
CAMBRIDGE, Mass.-(Business Wire)-September 2, 2008 - Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Morgan Stanley on Tuesday, September 9, 2008 at 9:45 a.m. EDT and by Robert W. Baird on Wednesday, September 10, 2008 at 12:40 p.m. EDT. The...
Gary Jacobson Named Executive Vice President and Chief Financial Officer at Ricerca Biosciences
CONCORD, Ohio-(Business Wire)-September 2, 2008 - Ricerca Biosciences, a uniquely integrated preclinical provider of contract research services for the pharmaceutical industry has named Gary Jacobson executive vice president and chief financial officer. In addition to his financial responsibilities...
Taking the Gold with Silver: B. Braun Introduces Industry-First Silver Impregnated Needle-Free Luer Access Device
BETHLEHEM, Pa.-(Business Wire)-September 2, 2008 - B. Braun Medical Inc. today announced it had received 510(k) clearance from the FDA for the industry's first silver-impregnated antibacterial Luer Access Device (LAD) designed to reduce potential catheter-related bloodstream infections. B. Braun's...
Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference and the Baird Small Cap Healthcare Conference
BOULDER, Colo.-(Business Wire)-September 2, 2008 - Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Morgan Stanley Global Healthcare Unplugged Conference on September 9 and the Baird Small Cap Healthcare Conference on September...
Families and Organizations Invited to Give BIG for Children in Need
PHILADELPHIA-(Business Wire)-September 2, 2008 - Individuals, families and organizations throughout the Philadelphia region are invited to help needy children this fall through Shire's "BIG GIVE" event benefiting Cradles to Crayons, a non-profit that helps children. The goal: to collect donated...
The Report Provides an Extensive Overview of Clinical Research Outsourcing and Role of CROs in Managing Clinical Trial Process
DUBLIN, Ireland-(Business Wire)-September 2, 2008 - Research and Markets has announced the addition of the "Clinical Research Outsourcing Where are We?" report to their offering. The report provides an extensive overview of clinical research outsourcing and role of CROs in managing clinical trial...
Brenda Fulmer Joins Searcy Denney Scarola Barnhart & Shipley
WEST PALM BEACH, Fla.-(Business Wire)-September 2, 2008 - South Florida law firm Searcy Denney Scarola Barnhart & Shipley, P.A. (Searcy Denney) is pleased to announce the addition of Brenda S. Fulmer as shareholder. Her practice will primarily focus in the areas of pharmaceutical and medical...
Bridge Laboratories' China Study Data Accepted by the FDA
GAITHERSBURG, Md.-(Business Wire)-September 2, 2008 - Bridge Laboratories announced today that the FDA has accepted data submitted from its Beijing facility on behalf of a US biotech client. The Good Laboratory Practices (GLP) nonhuman primate toxicology study data was generated and submitted last...
APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
SCHAUMBURG, Ill. & BAD HOMBURG V.D.H., Germany-(Business Wire)-September 2, 2008 - APP Pharmaceuticals, Inc. (Nasdaq:APPX) and Fresenius SE (XETRA:FRE) have received confirmation that the U.S. Federal Trade Commission (FTC) has completed its review of the proposed acquisition of APP...
BioMedEcon Reports Six Times Higher Psychiatric Medication Costs among Patients with Obsessive-Compulsive Disorder Compared to Patients with Depression
MOSS BEACH, Calif.-(Business Wire)-September 2, 2008 - BioMedEcon Group, a leading provider of health economics and outcomes research, presented findings of a unique nine-year retrospective claims analysis that compared the per-patient, median healthcare costs of newly-diagnosed patients with...
NIH Funds Discovery of New Influenza Inhibitors by Integral Molecular, Inc.
PHILADELPHIA-(Business Wire)-September 2, 2008 - Integral Molecular, Inc. initiates a federally-funded program to discover new drugs to combat influenza infection. Sponsored by the National Institute of Allergy and Infectious Diseases, Integral Molecular's R&D program will utilize its proprietary...
The Latest Global Pharma Industry Monitor Report is Now Available: Including Details Regarding Recent Mergers, Acquisitions and Major Pharma Deals
DUBLIN, Ireland-(Business Wire)-September 2, 2008 - Research and Markets has announced the addition of the "Global Pharma Industry Monitor" report to their offering. The Global Pharma Industry Monitor gives a summary and analysis of the global pharma market including, mergers, acquisitions...
Asterand plc Board Appointment
DETROIT-(Business Wire)-September 2, 2008 - Asterand plc (LSE: ATD), a leading provider of human tissue and services to pharmaceutical companies engaged in drug discovery research, announces the appointment of Jonathan J. Fleming as a Non-Executive Director. Mr. Fleming is currently the Managing...
CORRECTING and REPLACING Presentations on the Mechanism of Action of VEGFb(TM), the World's only "Triple Action Angiogenesis Modulator," Support VEGFb's Role as a Promising Treatment for Solid Cancers, Macular Degeneration, and Other Diseases
SUMMIT, N.J.-(Business Wire)-September 2, 2008 - Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: PRESENTATIONS ON THE MECHANISM OF ACTION OF VEGFB(TM), THE WORLD'S ONLY "TRIPLE ACTION ANGIOGENESIS MODULATOR," SUPPORT VEGFB'S...
MS Market is Estimated to Be Worth Almost US$8 Billion in 2008, with a Growth Rate of 10.6% Year-on-Year
DUBLIN, Ireland-(Business Wire)-September 2, 2008 - Research and Markets , sanofi-aventis' teriflunomide and Biogen Idec's BG-12 in Phase III development, and GSK/Mitsubishi Tanabe Pharma's firategrast, MediciNova's ibudilast and Biogen/UCB's CDP323 in Phase II development. Three companies have...
New Reporting from IntrinsiQ Measures Impact of Key Events on Oncology Drug Usage
WALTHAM, Mass.-(Business Wire)-September 2, 2008 - IntrinsiQ, LLC, the expert source for clinical oncology insight, today launched Event IntelliView, a new analysis tool that quantifies the real-world impact of key events in the lifecycle of medical oncology drugs. Pharmaceutical research teams...
Bayer USA Foundation Announces $100,000 Donation to The Wellness Community
PITTSBURGH-(Business Wire)-September 2, 2008 - The Bayer USA Foundation announced today that it has made a $100,000 donation to The Wellness Community (TWC), headquartered in Washington, D.C., in support of the launch of The Wellness Community's Cancer Survivorship Research & Training Institute...
Burnham Awarded $97.9 Million NIH Grant to Expand Small-Molecule Screening and Discovery Center
LA JOLLA, Calif.-(Business Wire)-September 2, 2008 - Burnham Institute for Medical Research (Burnham) announced today that it has been awarded a prestigious six-year, $97.9 million Molecular Libraries Probe Production Centers Network (MLPCN) grant from the National Institutes of Health (NIH...
Blue Vector VP of Marketing to Speak at RFID World 2008
PALO ALTO, Calif.-(Business Wire)-September 2, 2008 - Blue Vector Systems today announced that John Beans, Blue Vector's vice president of marketing, will be speaking at RFID World 2008, the industry's largest event featuring the largest display of RFID products and solutions anywhere in the...
miRagen Therapeutics, Inc. and Collaborators Publish Study Identifying microRNA Perturbations Following Acute Myocardial Infarction
BOULDER, Colo.-(Business Wire)-September 2, 2008 - miRagen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease based on microRNA biology, today announced the publication of novel research...
BIO-Europe 2008: The World's Leading Biotech Companies and Deal-Makers Get Ready for Three Days of Intense Partnering in Mannheim/Heidelberg
CARLSBAD, Calif. & WASHINGTON-(Business Wire)-September 2, 2008 - The leaders of the biotechnology industry will once again gather for BIO-Europe, the world's largest stand-alone partnering conference, in Mannheim/Heidelberg, Germany, November 17-19. With biotech deal-making still the thrill...
Jeffrey A. Leerink and Leerink Swann Present Big Brothers Big Sisters 5th Annual Fishing Tournament and Inaugural Golf Tournament
HYANNIS, Mass.-(Business Wire)-September 2, 2008 - A group of over 200 anglers and golfers will join healthcare investment bank Leerink Swann to support Big Brothers and Big Sisters on September 19 and 20. One hundred anglers on more than 20 boats are scheduled to take to the seas on Saturday...
Invitrogen and Cytovance(R) Biologics Collaborate to Develop New Bioreactor Manufacturing Process of Invitrogen's New CD OptiCHO(TM) Media Platform
OKLAHOMA CITY-(Business Wire)-September 2, 2008 - Cytovance(R) Biologics LLC, a biopharmaceutical contract manufacturing company specializing in mammalian cell culture, today announced the completion of a collaboration with Invitrogen's PD-Direct(R) Bioprocess Services. Cytovance Biologics has...
Metabolic Research, Inc. Elects Bradford van Siclen to its Board
LAS VEGAS-(Business Wire)-September 2, 2008 - Metabolic Research, Inc. (OTCBB:MTBR) announced today the election of Bradford van Siclen to its Board of Directors. Brad van Siclen has a MBA from New York University's Stern School of Business with emphasis on Finance and Accounting. His career...
Phase Forward to Present at the Thomas Weisel Partners Healthcare Conference 2008
WALTHAM, Mass.-(Business Wire)-September 2, 2008 - Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and chief financial officer, Rodger Weismann, will...
Adolor Regains Rights to Entereg(R) (alvimopan) for OBD
EXTON, Pa.-(Business Wire)-September 2, 2008 - Adolor Corporation (Nasdaq: ADLR) announced today that GlaxoSmithKline (GSK) has returned to Adolor worldwide rights related to Entereg(R) (alvimopan) for chronic opioid bowel dysfunction (OBD). GSK is retaining rights to Entereg for postoperative ileus...
Lipitor 80 mg Provided Sustained Risk Reduction of Cardiovascular Events in Patients with Heart Disease During the Five-Year TNT Trial
NEW YORK-(Business Wire)-September 2, 2008 - Pfizer announced that in patients with established heart disease, Lipitor(R) (atorvastatin calcium) 80 mg not only significantly reduced the relative risk of suffering a first cardiovascular event by 19 percent compared to Lipitor 10 mg but also...
Idera Pharmaceuticals Announces Milestone Payment Under Asthma and Allergy Collaboration
CAMBRIDGE, Mass.-(Business Wire)-September 2, 2008 - Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that it will receive a milestone payment from Novartis under the two companies' research collaboration and license agreements. Under the terms of the agreement, the payment was...
Allos Therapeutics to Present at the 3rd Annual Citi Biotech Day
WESTMINSTER, Colo.-(Business Wire)-September 2, 2008 - Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that members of the Company's senior management will...
Optimer Pharmaceuticals Completes Enrollment in Second Prulifloxacin Phase 3 Clinical Trial
SAN DIEGO-(Business Wire)-September 2, 2008 - Optimer Pharmaceuticals, Inc. (Nasdaq:OPTR) today announced that the company has completed enrollment in the second of two planned phase 3 clinical trials evaluating the safety and efficacy of Prulifloxacin for the treatment of infectious diarrhea in...
Targanta Therapeutics Announces Positive Top-Line Results from Oritavancin Phase 2 SIMPLIFI Trial
CAMBRIDGE, Mass.-(Business Wire)-September 2, 2008 - Targanta Therapeutics Corporation (Nasdaq: TARG) today announced positive top-line results from a Phase 2 clinical trial investigating the efficacy and safety of oritavancin at Single or Infrequent Doses for the Treatment of Complicated Skin and...
Cubist Pharmaceuticals to Host Investor Event: Act 2 - Raising the Curtain on Cubist's Pipeline
LEXINGTON, Mass.-(Business Wire)-September 2, 2008 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will host an invitation-only Investor Event at the Back Bay Events Center in Boston at 4:30 P.M. ET on Monday, September 8th, 2008. The presentations will focus on the...
AtheroGenics Noteholders Expect Company Will Elect Not to Pay 2008 Notes When Due
ATLANTA-(Business Wire)-September 2, 2008 - CNH Partners, LLC, Tamalpais Asset Management LP, Tang Capital Partners, LP, and Zazove Associates LLC (the "08 Noteholders"), which collectively hold approximately 96% of the outstanding 4 1/2 % Convertible Notes Due 2008 (the "08 Notes") issued by...
New Leaf Venture Partners Expands Leadership Team, Naming Liam Ratcliffe, M.D., Ph.D., as Venture Partner
NEW YORK-(Business Wire)-September 2, 2008 - New Leaf Venture Partners (NLV Partners) announced today the appointment of Liam Ratcliffe, M.D., Ph.D., as venture partner. Dr. Ratcliffe recently served as Senior Vice President and Global Head of Clinical Research and Development for Pfizer. Dr...
Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
AUSTIN, Texas-(Business Wire)-September 2, 2008 - Introgen Therapeutics, Inc. (NASDAQ:INGN), a developer of targeted molecular therapies for cancer, today announced that the United States Food and Drug Administration (FDA) notified the Company that its Biologics License Application (BLA) for...
Research and Markets: CNS Drug Discoveries Alzheimer's Disease Chapter Predicts the Considerable Changes in the AD Market That May Occur by 2014
DUBLIN, Ireland-(Business Wire)-September 2, 2008 - Research and Markets . The current front runner is Wyeth/Elan's bapineuzumab, although this too is facing challenges in development. It may be some time before the first disease-modifying agents emerge which could revolutionise the way AD is...
Alpharma Adopts Limited Duration Shareholder Rights Plan
BRIDGEWATER, N.J.-(Business Wire)-September 2, 2008 - Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced that its Board of Directors has adopted a limited duration shareholder rights plan (the "Rights Plan"). The Rights Plan has been adopted in response to King...
Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets
MANSFIELD, Mass.-(Business Wire)-September 2, 2008 - Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has reached an agreement with Purdue Pharma L.P. to end a patent infringement lawsuit between them. In...
Acorda Therapeutics to Present at the 3rd Annual Citi Biotech Day Conference
HAWTHORNE, N.Y.-(Business Wire)-September 2, 2008 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present a corporate overview at the upcoming 3rd Annual Citi Biotech Day Conference on Monday, September 08, 2008 at 9:45 a.m. ET at the Citi...
Akorn-Strides, LLC Announces FDA Approvals for Dexamethasone Sodium Phosphate Injection USP, 4 mg (base)/mL and Dexamethasone Sodium Phosphate Injection USP, 10 mg (base)/mL
BUFFALO GROVE, Ill.-(Business Wire)-September 2, 2008 - Akorn-Strides, LLC today announced the approval of two ANDAs for Dexamethasone Sodium Phosphate Injection USP, 4 mg (base)/mL in 1mL, 5 mL, and 30 mL vials, and Dexamethasone Sodium Phosphate Injection USP, 10 mg (base)/mL in 10 mL vials...
Celera to Webcast Its Analyst and Investor Meeting on September 9, 2008
ALAMEDA, Calif.-(Business Wire)-September 2, 2008 - Celera Corporation (NASDAQ:CRA), announced today that it will webcast its Analyst & Investor Meeting in New York, NY, on Tuesday, September 9, 2008. The live webcast is scheduled to begin at 8:30 a.m. Eastern Time. At the meeting, Celera's...
Aethlon Medical To Present at 2008 Southern California Investor Conference
SAN DIEGO-(Business Wire)-September 2, 2008 - Aethlon Medical, Inc. (OTCBB:AEMD) today announced that Chairman and Chief Executive Officer, James A. Joyce, will present a company overview at the California Stock Report's 2008 Southern California Investor Conference being held tomorrow, September...
Alpharma Announces Acceptance of the EMBEDA(TM) Capsule NDA Filing
BRIDGEWATER, N.J.-(Business Wire)-September 2, 2008 - Alpharma Inc. (NYSE:ALO), a global specialty pharmaceutical company, today announced that the United States Food and Drug Administration ("FDA") has advised the Company that its New Drug Application ("NDA") for EMBEDA(TM) (morphine sulfate...
Fibrex Medical Report Positive Phase II Results for FX06
CAMBRIDGE, Mass. & VIENNA, Austria-(Business Wire)-September 2, 2008 - Fibrex Medical, a biopharmaceutical company focusing on cardiovascular and inflammatory diseases, today announced positive Phase II results for FX06, a peptide for the treatment of reperfusion injury - the damage to heart...
ZymoGenetics to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
SEATTLE-(Business Wire)-September 2, 2008 - ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that Douglas E. Williams, Ph.D., President and Chief Scientific Officer, will provide an update on company activities at the Morgan Stanley Global Healthcare Unplugged Conference in New York on Tuesday...
ZymoGenetics Earns Milestone Payment for RECOTHROM(R) European Filing
SEATTLE-(Business Wire)-September 2, 2008 - ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that it will receive a $5 million milestone payment from Bayer HealthCare, which was triggered by the submission of the Marketing Authorization Application to the European Medicines Agency (EMEA) for...
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
PRINCETON, N.J. & NEW YORK-(Business Wire)-September 2, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc (NYSE: PFE) announced today the results of a Phase 2 dose-ranging study (APPRAISE-1) involving the investigational compound apixaban in patients with acute coronary syndrome...
Western European Diabetes Market Shows Movement to Exclusive Pill Therapy, According to Study by GfK Market Measures' Roper Global Diabetes Group
LONDON-(Business Wire)-September 2, 2008 - For diabetes patients across the Western European countries of France, Germany, Italy, the Netherlands, Spain and the United Kingdom, exclusive pill therapy is increasingly the treatment of choice. And while the proportion of patients receiving no...
Pharmaceutical Supply System Activates Rx Response to Provide Single Point of Contact for Resolution of Pharmaceutical Supply Obstacles Associated with Hurricane Gustav
WASHINGTON-(Business Wire)-September 1, 2008 - Rx Response, an unprecedented initiative of America's pharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, has been officially activated due to Hurricane Gustav. Rx Response was...
The Top 10 World's Leading Pharmaceutical Companies: Roche is Essential Reading for the Pharmaceutical Industry Executive
DUBLIN, Ireland-(Business Wire)-September 1, 2008 - Research and Markets ; major drug categories, including cardiovascular, gastrointestinal, antibiotics, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, and others. In addition, the report reviews major U.S...
Aetna Assists Those Affected by Hurricane Gustav
HARTFORD, Conn.-(Business Wire)-September 1, 2008 - Aetna (NYSE: AET) announced today they have temporarily lifted some medical and pharmacy policy requirements for members affected by Hurricane Gustav, including relief workers traveling to the impacted areas. Aetna members from the hurricane zone...
Research and Markets: Available Now - Optimer Pharmaceuticals Inc: Premium Company Profile
DUBLIN, Ireland-(Business Wire)-September 1, 2008 - Research and Markets Table 9: Optimer Pharmaceuticals - Key Competitors Table 10: Optimer Pharmaceuticals- Key Suppliers Table 11: Optimer Pharmaceuticals- Key Clients Table 12: Optimer Pharmaceuticals- Key Shareholders Table 13: Optimer...
Research and Markets: Out Now - CNS Drug Discoveries: Parkinson's Disease Chapter
DUBLIN, Ireland-(Business Wire)-September 1, 2008 - Research and Markets . Although this neurodegenerative disease affects approximately 1% of the population its prevalence increases with age, thus it is likely to become more commonplace due to patient demographics and become a greater burden to...
Shionogi & Co., Ltd. to Acquire Sciele Pharma, Inc.
ATLANTA & OSAKA, Japan-(Business Wire)-September 1, 2008 - Shionogi & Co., Ltd. and Sciele Pharma, Inc. (NASDAQ:SCRX) today announced that they have entered into a definitive agreement under which Shionogi & Co., Ltd. will acquire Sciele Pharma, Inc. Under the terms of agreement and...
